Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Cellular and Molecular Biology Letters

Editor-in-Chief: /


IMPACT FACTOR 2016: 1.260
5-year IMPACT FACTOR: 1.506

CiteScore 2016: 1.56

SCImago Journal Rank (SJR) 2016: 0.615
Source Normalized Impact per Paper (SNIP) 2016: 0.470

Online
ISSN
1689-1392
See all formats and pricing
More options …
Volume 13, Issue 3 (Sep 2008)

Lipid changes occuring in the course of hematological cancers

Małgorzata Kuliszkiewicz-Janus
  • Department of Haematology, Wrocław Medical University, Pasteura 4, 50-367, Wrocław, Poland
  • Academic Centre for the Biotechnology of Lipid Aggregates, Wrocław, Poland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rafał Małecki
  • Department of Angiology, Arterial Hypertension and Diabetology, Wrocław Medical University, Borowska 213, 50-556, Wrocław, Poland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Abdulrahman Mohamed
Published Online: 2008-07-07 | DOI: https://doi.org/10.2478/s11658-008-0014-9

Abstract

The relationship between plasma lipid levels and mortality from cardiovascular diseases has been shown in many studies, but there has been far less investigation into their relationship to non-cardiovascular diseases. The aim of this study was to investigate the lipid profile of individuals with hematological malignancies and its relationship to disease activity. 238 patients were included in the study: 84 with acute leukemia, 62 with non-Hodgkin lymphoma, 35 with Hodgkin’s lymphoma, 32 with multiple myeloma, and 25 with myeloproliferative syndrome. The HDL cholesterol level of the patients differed to that of the individuals in the control group in the active disease period for all the analyzed disorders, but only remained statistically significant in the acute leukemia and non-Hodgkin lymphoma groups during the remission period. Smaller differences were observed for the remaining lipid fractions, except for the triglyceride level, which increased in the active disease period in all the analyzed disorders except non-Hodgkin lymphoma. The most pronounced changes in the lipid fractions occurred in the HDL cholesterol level, and were the most remarkable for acute leukemia.

Keywords: Lipid profile; HDL-C; Hematological cancers

  • [1] Castelli, W.P., Garrison, R.J., Wilson, P.W., Abbott, R.D., Kalousdian, S. and Kannel, W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835–2738. http://dx.doi.org/10.1001/jama.256.20.2835CrossrefGoogle Scholar

  • [2] Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383–1389. Google Scholar

  • [3] Kreger, B.E., Anderson, K.M., Schatzkin, A. and Splansky, G.L. Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer 70 (1992) 1038–1043. http://dx.doi.org/10.1002/1097-0142(19920901)70:5<1038::AID-CNCR2820700505>3.0.CO;2-MCrossrefGoogle Scholar

  • [4] Sherwin, R.W., Wentworth, D.N., Cutler, J.A., Hulley, S.B., Kuller, L.H. and Stamler, J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 257 (1987) 943–948. http://dx.doi.org/10.1001/jama.257.7.943CrossrefGoogle Scholar

  • [5] Fiorenza, A.M., Branchi, A. and Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. Clin. Lab. Res. 30 (2000) 141–145. http://dx.doi.org/10.1007/s005990070013CrossrefGoogle Scholar

  • [6] Musolino, C., Calabro, L., Bellomo, G., Cincotta, M., Di Giacomo, V., Pezzano, C., Loteta, B., Rizzo, V., Guglielmo, S. and Alonci, A. Lipid profile in hematologic neoplasms. Recenti Prog. Med. 93 (2002) 298–301. Google Scholar

  • [7] Dessi, S., Batetta, B., Pulisci, D., Accogli, P., Pani, P. and Broccia, G. Total and HDL cholesterol in human hematologic neoplasms. Int. J. Hematol. 54 (1991) 483–486. Google Scholar

  • [8] Scribano, D., Baroni, S., Pagano, L., Zuppi, C., Leone, G. and Giardina, B. Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia. Haematologica 81 (1996) 343–345. Google Scholar

  • [9] Moschovi, M., Trimis, G., Apostolakou, F., Papassotiriou, I. and Tzortzatou-Stathopoulou, F. Serum lipid alterations in acute lymphoblastic leukemia of childhood. J. Pediatr. Hematol. Oncol. 26 (2004) 289–293. http://dx.doi.org/10.1097/00043426-200405000-00006CrossrefGoogle Scholar

  • [10] Kuliszkiewicz-Janus, M., Tuz, M.A. and Baczyński, S. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia. Biochim. Biophys. Acta 1737 (2005) 11–15. Google Scholar

  • [11] Lorenc, J., Kozak-Michałowska, I. and Polkowska-Kulesza, E. Disorders of lipid and lipoprotein metabolism in patients with chronic lymphocytic leukemia. I. Preliminary evaluation of lipemia and HDL fractions in various stages of the disease. Przegl. Lek. 46 (1989) 713–718. Google Scholar

  • [12] Ginsberg, H.N., Le, N.A. and Gilbert, H.S. Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia. Metabolism 35 (1986) 878–882. http://dx.doi.org/10.1016/0026-0495(86)90232-5CrossrefGoogle Scholar

  • [13] Gilbert, H.S. and Ginsberg, H. Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemia. Cancer 51 (1983) 1428–1433. http://dx.doi.org/10.1002/1097-0142(19830415)51:8<1428::AID-CNCR2820510817>3.0.CO;2-XCrossrefGoogle Scholar

  • [14] Ghalaut, V.S., Pahwa, M.B., Sunita and Ghalaut, P.S. Alteration in lipid profile in patients of chronic myeloid leukemia before and after chemotherapy. Clin. Chim. Acta 366 (2006) 239–428. http://dx.doi.org/10.1016/j.cca.2005.10.022CrossrefGoogle Scholar

  • [15] Hachem, H., Favre, G., Ghalim, N., Puchois, P., Fruchart, J.C. and Soula, G. Quantitative abnormalities of lipoprotein particles in multiple myeloma. J. Clin. Chem. Clin. Biochem. 25 (1987) 675–679. Google Scholar

  • [16] Kuliszkiewicz-Janus, M. and Baczyński, S. Chemotherapy-associated changes in 31P MRS spectra of sera from patients with multiple myeloma. NMR Biomed 8 (1995) 127–132. http://dx.doi.org/10.1002/nbm.1940080308CrossrefGoogle Scholar

  • [17] Kuliszkiewicz-Janus, M. and Baczyński, S. Application of 31P NMR spectroscopy to monitor chemotherapy-associated changes of serum phospholipids in patients with malignant lymphomas. Magn. Reson. Med. 35 (1996) 449–456. CrossrefGoogle Scholar

  • [18] van Leeuwen, H.J., Heezius, E.C., Dallinga, G.M., van Strijp, J.A., Verhoef, J. and van Kessel, KP. Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med. 31 (2003) 1359–1366. http://dx.doi.org/10.1097/01.CCM.0000059724.08290.51CrossrefGoogle Scholar

  • [19] Sakashita, A.M., Bydlowski, S.P., Chamone, D.A. and Maranhao RC. Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocytic leukemia. Ann. Hematol. 79 (2000) 687–690. http://dx.doi.org/10.1007/s002770000205CrossrefGoogle Scholar

  • [20] Baroni, S., Scribano, D., Zuppi, C., Pagano, L., Leone, G. and Giardina, B. Prognostic relevance of lipoprotein cholesterol levels in acute lymphocytic and nonlymphocytic leukemia. Acta Haematol. 96 (1996) 24–28. http://dx.doi.org/10.1159/000203710CrossrefGoogle Scholar

  • [21] Moran, C.S., Campbell, J.H. and Campbell, G.R. Human leukemia inhibitory factor upregulates LDL-C receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbit. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1267–1273. CrossrefGoogle Scholar

  • [22] Goncalves, R.P., Rodrigues, D.G. and Maranhao, R.C. Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells. Leuk. Res. 29 (2005) 955–959. http://dx.doi.org/10.1016/j.leukres.2005.01.013CrossrefGoogle Scholar

About the article

Published Online: 2008-07-07

Published in Print: 2008-09-01


Citation Information: Cellular and Molecular Biology Letters, ISSN (Online) 1689-1392, DOI: https://doi.org/10.2478/s11658-008-0014-9.

Export Citation

© 2008 University of Wrocław, Poland. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Jonathan S. Rink, Shuo Yang, Osman Cen, Tim Taxter, Kaylin M. McMahon, Sol Misener, Amir Behdad, Richard Longnecker, Leo I. Gordon, and C. Shad Thaxton
Molecular Pharmaceutics, 2017
[2]
Tze Ping Loh, Michelle Poon, Gloria Hui Jia Chan, Sunil Kumar Sethi, and Alvin Wong
Pathology, 2017, Volume 49, Number 5, Page 550
[3]
Zorica Cvetković, Maja Milošević, Bora Cvetković, Romana Masnikosa, Aleksandra Arsić, Snježana Petrović, and Vesna Vučić
Leukemia Research, 2017, Volume 54, Page 39
[4]
Irfan Yavasoglu, Gokhan Sargin, Fergun Yilmaz, Sermin Altındag, Gulsum Akgun, Anil Tombak, Bila Toka, Sinan Dal, Hasan Ozbas, Guven Cetin, Ayhan Donmez, Zeynep Arzu Yegin, Oktay Bilgir, Naci Tiftik, Sehmus Ertop, Orhan Ayyildiz, Mehmet Sonmez, Gokhan Pektas, Gurhan Kadıkoylu, Murat Tombuloglu, and Zahit Bolaman
Journal of the National Medical Association, 2017, Volume 109, Number 1, Page 23
[5]
S. G. Vladimirova and L. N. Tarasova
Terapevticheskii arkhiv, 2016, Volume 88, Number 3, Page 116
[6]
Hina Usman, Fatima Ameer, Rimsha Munir, Areeb Iqbal, Muhammad Zaid, Shahida Hasnain, Lisa Scandiuzzi, and Nousheen Zaidi
Clinica Chimica Acta, 2016, Volume 457, Page 12
[7]
Areeb Iqbal, Muhammad Zaid, Rimsha Munir, Hina Usman, Hubert Kalbacher, Lisa Scandiuzzi, and Nousheen Zaidi
Clinica Chimica Acta, 2016, Volume 452, Page 129
[8]
Xibiao Ye, Ayat Mneina, James B. Johnston, and Salaheddin M. Mahmud
Hematological Oncology, 2017, Volume 35, Number 2, Page 206
[9]
Danitza Pradelli, Davide Soranna, Antonella Zambon, Alberico Catapano, Giuseppe Mancia, Carlo La Vecchia, and Giovanni Corrao
Cancer Medicine, 2015, Volume 4, Number 5, Page 770
[10]
Cliona M. McHale, Luoping Zhang, Qing Lan, Guilan Li, Alan E. Hubbard, Matthew S. Forrest, Roel Vermeulen, Jinsong Chen, Min Shen, Stephen M. Rappaport, Songnian Yin, Martyn T. Smith, and Nathaniel Rothman
Genomics, 2009, Volume 93, Number 4, Page 343
[11]
Hina Usman, Rida Rashid, Fatima Ameer, Areeb Iqbal, Muhammad Zaid, Shahida Hasnain, Hubert Kalbacher, and Nousheen Zaidi
Clinica Chimica Acta, 2015, Volume 444, Page 43
[12]
Wael Al-Zhoughbi, Jianfeng Huang, Ganapathy S. Paramasivan, Holger Till, Martin Pichler, Barbara Guertl-Lackner, and Gerald Hoefler
Seminars in Oncology, 2014, Volume 41, Number 2, Page 281
[13]
Liang Wang, Pei-dong Chi, Hao Chen, Jin Xiang, Zhong-jun Xia, and Yu-jing Zhang
Tumor Biology, 2014, Volume 35, Number 3, Page 2141
[14]
Hiroshi Fujita, Tamae Hamaki, Naoko Handa, Akira Ohwada, Junji Tomiyama, and Shigeko Nishimura
Journal of Clinical and Experimental Hematopathology, 2012, Volume 52, Number 2, Page 85
[15]
Jianfeng Huang, Suman Kumar Das, Pooja Jha, Wael Al Zoughbi, Silvia Schauer, Thierry Claudel, Veronika Sexl, Paul Vesely, Ruth Birner-Gruenberger, Dagmar Kratky, Michael Trauner, and Gerald Hoefler
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013, Volume 1831, Number 10, Page 1555
[16]
Yana Vinogradova, Carol Coupland, and Julia Hippisley-Cox
BMC Cancer, 2011, Volume 11, Number 1

Comments (0)

Please log in or register to comment.
Log in